mRNA |
QS11 |
GDSC1000 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
GW 441756 |
GDSC1000 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
-0.025 |
0.4 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
CP724714 |
GDSC1000 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.4 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
0.028 |
0.4 |